Vancomycin: The pendulum swings

被引:5
作者
Scheetz, Marc H. [1 ,2 ,3 ]
机构
[1] Midwestern Univ Chicago, Coll Pharm, Dept Pharm Practice, Downers Grove, IL 60515 USA
[2] Midwestern Univ Chicago, Coll Pharm, Pharmacometr Ctr Excellence, Downers Grove, IL 60515 USA
[3] Northwestern Med, Dept Pharm, Chicago, IL 60611 USA
关键词
STAPHYLOCOCCUS-AUREUS INFECTIONS; DISEASES SOCIETY; AMERICA;
D O I
10.1093/ajhp/zxaa076
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:810 / 811
页数:2
相关论文
共 10 条
  • [2] Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model
    Avedissian, Sean N.
    Pais, Gwendolyn M.
    O'Donnell, J. Nicholas
    Lodise, Thomas P.
    Liu, Jiajun
    Prozialeck, Walter C.
    Joshi, Medha D.
    Lamar, Peter C.
    Becher, Leighton
    Gulati, Anil
    Hope, William
    Scheetz, Marc H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (08) : 2326 - 2334
  • [3] Cooper GL., 1986, Vancomycin: A Comprehensive Review of 30 Years of Clinical Experience
  • [4] RETROSPECTIVE STUDY OF THE TOXICITY OF PREPARATIONS OF VANCOMYCIN FROM 1974 TO 1981
    FARBER, BF
    MOELLERING, RC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) : 138 - 141
  • [5] VANCOMYCIN IN SERIOUS STAPHYLOCOCCAL INFECTIONS
    GERACI, JE
    WELLMAN, WE
    NICHOLS, DR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1962, 109 (05) : 507 - +
  • [6] Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
    Liu, Catherine
    Bayer, Arnold
    Cosgrove, Sara E.
    Daum, Robert S.
    Fridkin, Scott K.
    Gorwitz, Rachel J.
    Kaplan, Sheldon L.
    Karchmer, Adolf W.
    Levine, Donald P.
    Murray, Barbara E.
    Rybak, Michael J.
    Talan, David A.
    Chambers, Henry F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) : E18 - E55
  • [7] The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)
    Lodise, Thomas P., Jr.
    Rosenkranz, Susan L.
    Finnemeyer, Matthew
    Evans, Scott
    Sims, Matthew
    Zervos, Marcus J.
    Creech, C. Buddy
    Patel, Pratish C.
    Keefer, Michael
    Riska, Paul
    Silveira, Fernanda P.
    Scheetz, Marc
    Wunderink, Richard G.
    Rodriguez, Martin
    Schrank, John
    Bleasdale, Susan C.
    Schultz, Sara
    Barron, Michelle
    Stapleton, Ann
    Wray, Dannah
    Chambers, Henry
    Fowler, Vance G., Jr.
    Holland, Thomas L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1536 - 1545
  • [8] Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI [10.2146/ajhp080434, 10.1086/600877]
  • [9] Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
    Rybak, Michael J.
    Le, Jennifer
    Lodise, Thomas P.
    Levine, Donald P.
    Bradley, John S.
    Liu, Catherine
    Mueller, Bruce A.
    Pai, Manjunath P.
    Wong-Beringer, Annie
    Rotschafer, John C.
    Rodvold, Keith A.
    Maples, Holly D.
    Lomaestro, Benjamin
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1361 - 1364
  • [10] Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia
    Scheetz, MH
    Wunderink, RG
    Postelnick, MJ
    [J]. PHARMACOTHERAPY, 2006, 26 (04): : 539 - 550